Clinical Trials Logo

Apnea, Postanesthetic clinical trials

View clinical trials related to Apnea, Postanesthetic.

Filter by:
  • None
  • Page 1

NCT ID: NCT05550584 Completed - Anesthesia Clinical Trials

High Flow Oxygen During Operative Hysteroscopy.

HOPE
Start date: June 17, 2022
Phase: N/A
Study type: Interventional

High-flow nasal cannula (HFNC) oxygen therapy represents an open circuit ventilation system that uses flows up to 70 L/min of 100% oxygen through the Optiflow THRIVETM device (Fisher and Paykel Healthcare Ltd, Auckland, New Zealand). Compared to conventional oxygen therapy systems, the heating and humidification of the flows facilitate tolerability by the patient, allow to reach higher and more stable inspiratory fractions of oxygen, produce a flow-dependent effect of continuous positive airway pressure and by reducing dead space, have the potential to increase alveolar volume and improve gas exchanges. The use of HFNC is increased in anesthesia as the only airways management technique during short-term procedures under procedural sedation or general anesthesia. Operative hysteroscopy is a short-term procedure (<30 minutes), usually performed in a day-hospital regimen, under procedural sedation. In case of apnea and/or hypoventilation, or for long and complex hysteroscopic procedures, the patient can be ventilated through facial or laryngeal masks. The primary objective of this prospective randomized controlled trial is to compare the rate of success of ventilation using the THRIVE device to laryngeal mask ventilation during operative hysteroscopies under procedural sedation. Secondary objectives will be the comparison of the percentage of complications in terms of inability to manage the airways, episodes of hypotension, cardiac arrhythmias, post-operative nausea and vomiting, degree of dyspnea and comfort of the patient in the Post-Anesthesia Care Unit between the two methods.

NCT ID: NCT03843580 Completed - Anesthesia Clinical Trials

Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) Could Decrease the Incidence of Oxygen Desaturation During Suspension Laryngoscopy: a Randomized Controlled Trial (Optilaryngo)

optilaryngo
Start date: April 23, 2019
Phase: N/A
Study type: Interventional

Suspension laryngoscopy is realised during apnea. In effect, surgeons are in the mouth of the patient and we can't have access at the aiways. So investigators like to use a Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) to increase time of apnea and decrease the impact of oxygen desaturation.

NCT ID: NCT03290859 Completed - Hypoxemia Clinical Trials

Race-Specific Propofol Titration to Effect for Procedural Sedation

Start date: January 5, 2018
Phase:
Study type: Observational

Prospectively evaluate newly established guidelines and make clinicians aware of inter-racial difference in propofol sensitivity.